Navigation Links
Eurofins MWG Operon adds Roche GS Junior to its sequencer fleet
Date:9/28/2010

Ebersberg, Germany, September 28, 2010 - Eurofins MWG Operon, an expert in next generation sequencing (NGS) has expanded its sequencing capacity with a Roche GS Junior. The GS Junior is the optimum system for the sequencing of smaller scale projects which would require only one eighth of the capacity of a GS FLX Titanium run or which would not be suitable for an Illumina run. As a consequence, the GS Junior adds a higher degree of flexibility in project planning and will have a positive impact on the turn around time for small sized projects. In addition, it allows new possibilities in quality control, e.g. library checking in advance of starting high throughput sequencing or the validation of NGS data for molecular diagnostics.

"We are pleased to integrate this new system in our NGS service pipeline. It allows our customers to plan experiments that have not been possible in this short timeframe before. In addition, it will secure the high quality of our high throughput sequencing projects and allow us to develop new applications in a reasonable time and at reasonable cost", says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services.


'/>"/>

Contact: Dr. Georg Gradl
georggradl@eurofins.com
49-809-282-89945
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
2. Eurofins MWG Operon and Genomatix developed most complete human exome array
3. Eurofins MWG Operon and Genomatix launch strategic alliance
4. Verizon Business to Provide Global IP for Eurofins Scientific
5. Texas petrochemical emissions down, but still underestimated, says study
6. Rochester study connects workplace turmoil, stress and obesity
7. MBL scientist awarded next-generation DNA sequencer to monitor water quality
8. Fishing fleet working 17 times harder than in 1880s to make same catch
9. The European project, Eurofleets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology: